Immunotherapy Drugs Market Size, Share, Trends, Growth 2032

Immunotherapy Drugs Industry Prospective:

The global immunotherapy drugs market size was worth around USD 106.36 billion in 2023 and is predicted to grow to around USD 294.94 billion by 2032 with a compound annual growth rate (CAGR) of roughly 12% between 2024 and 2032.

Request Free Sample

In order to give the users of this report a comprehensive view of the immunotherapy drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Immunotherapy Drugs Market: Growth Drivers

Immunotherapy uses the body’s immune system to fight against various disorders, such as cancer, infectious diseases, autoimmune, and inflammatory diseases. Immunotherapy includes the use of monoclonal antibodies and various checkpoint inhibitors that disrupt signals that protect cancer cells from immune attack, preventive, and therapeutic vaccines, and cytokines, such as interferon, interleukin etc. Immunotherapy is widely adopted in cancer treatments, owing to lesser side-effects as compared to chemotherapy.

The prevalence of cancer is growing worldwide and it was the second leading cause of death in the year 2018. As per the World Health Organization (WHO) 2018 estimates, there were about 18.1 million new cancer cases and 9.6 million global deaths caused by cancer. The incidence of lifestyle-related disorders is rapidly increasing, which, in turn, is likely to drive the demand for immunotherapy drugs market in the future. The increasing preference for targeted therapy with lesser side-effects over traditional therapy is anticipated to further fuel the immunotherapy drugs market in the future.

Additionally, the emergence of new biosimilars, rapid drug approvals, and increased demand for monoclonal antibodies (mAbs) are projected to boost the immunotherapy drugs market growth over the estimated timeframe.

Request Free Sample

Other factors likely to contribute toward the immunotherapy drugs market growth are rising geriatric population base, increasing health awareness, increased disposable income and healthcare spending, and favorable reimbursement policies. However, the high cost of immunotherapy drugs might limit the immunotherapy drugs market in the future. Emerging markets and immunotherapy as a substitute for chemotherapy is likely to create new growth opportunities for the immunotherapy drugs market on a global scale.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immunotherapy drugs market on a global and regional basis.

Immunotherapy Drugs Market: Segmentation

The global immunotherapy drugs market is segmented based on drug type, therapeutic application, and end-user.

By drug type, the market is segmented into adult vaccines, monoclonal antibodies, checkpoint inhibitors, interleukins, interferon alpha and beta, and others. Preventive vaccines and therapeutic vaccines comprise the adult vaccines segment. Monoclonal antibodies drug type segment held the largest share of the global immunotherapy drug market in 2017, owing to the preference for targeted therapy with lesser side effects.

By therapeutic application, this global market is segmented into autoimmune and inflammatory diseases, cancer, infectious diseases, and others. Cancer segment is further divided into the solid tumor and malignant. The cancer therapeutic application segment held the largest share of global immunotherapy drugs market, owing to increasing cancer prevalence globally.

Hospitals, clinics, and others form the end-user segment of the global immunotherapy drugs market. Hospitals dominated the immunotherapy drugs market in 2017 and are expected to lead in the future as well.

Immunotherapy Drugs Market: Report Scope

Immunotherapy Drugs Market: Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S. Canada, Germany, France, the UK, China, Japan, India, and Brazil.

By region, North America dominated the global immunotherapy drugs market in 2018 with a revenue share of about 40%. This can be attributed to the presence of key players, increasing preference for targeted immunotherapy over other therapies, favorable reimbursement policies, and developed healthcare infrastructure. North America is likely to maintain its top position over the forecast time period as well. Europe is the second largest regional market for immunotherapy drugs in 2018.

The Asia Pacific region is estimated to register the highest CAGR over the forecast time period, owing to increasing health awareness, growing healthcare spending, and rising disposable income. The Middle Eastern and African region is likely to experience noticeable growth in the years ahead. Latin America is projected to exhibit a moderate rate of growth for immunotherapy drugs market over the forecast time period.

Immunotherapy Drugs Market: Competitive Analysis

The global immunotherapy drugs market is dominated by players like:

• F. Hoffmann-La Roche AG
• Amgen, Inc
• Novartis International AG
• AbbVie, Inc
• Merck & Co., Inc
• GlaxoSmithKline
• Eli Lilly and Company
• Bristol-Myers Squibb
• AstraZeneca plc
• Johnson & Johnson

This report segments the global immunotherapy drugs market into:

Global Immunotherapy Drugs Market: By Drug Type

• Monoclonal Antibodies
• Adult Vaccines
  • Preventive Vaccines
  • Therapeutic Vaccines
• Checkpoint Inhibitors
• Interferons Alpha and Beta
• Interleukins
• Others

Global Immunotherapy Drugs Market: By Therapeutic Application

• Cancer
  • Solid Tumor
  • Malignant
• Autoimmune and Inflammatory Diseases
• Infectious Diseases
• Others

Global Immunotherapy drugs Market: By End-User

• Hospitals
• Clinics
• Others

Global Immunotherapy Drugs Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa